A new double-duty hydrogel developed by scientists was found to offer double punch against orthopedic bone infections. The gel both attacks the bacteria and encourages bone regrowth with a single application containing two active components.
The injectable hydrogel, which is a network of cross-linked polymer chains, contains the enzyme lysostaphin and the bone-regenerating protein BMP-2. In a new study using a small animal model, researchers at the Georgia Institute of Technology showed significant reduction in an infection caused by Staphylococcus aureus - a common infection in orthopedic surgery - along with regeneration within large bone defects.
Mastoiditis
Mastoiditis, infection of mastoid bone, results from spread of middle ear infection like bacterial infections, presenting with redness or swelling behind ear.
Advertisement
‘Newly developed hydrogel helps treat and prevent bone infections during surgery. ’
Tweet it Now
"Treatment for bone infections now often requires two surgeries to both eliminate the infection and heal the injured bone," said Andrés J. García, executive director of the Parker H. Petit Institute for Bioengineering & Bioscience at the Georgia Institute of Technology. "Our idea was to develop a bifunctional material that does both things in a single step. That would be better for the patient, cost less and reduce hospitalization time. We have shown that we can engineer the hydrogel to control the delivery and release of both the antimicrobial enzyme and the regenerative protein."
The hydrogel-based therapy could be used to treat established bone infections, and as a prophylactic during surgery to prevent infection. The study, funded by the National Institutes of Health, was reported May 17 in the journal Science Advances.
![Osteomyelitis]( "Osteomyelitis")
An infection of a bone is called osteomyelitis. Osteomyelitis can be acute or a chronic and can spread through the haematogenous or contiguous route.
Bone infections today are often treated with systemic antibiotics and surgery to clean the injury. If the infection occurs with implants, they often must be removed. Once the infection is gone, additional surgery may be required to implant proteins that stimulate bone regrowth and restore the implant. And the dead bacteria can prompt a harmful inflammatory reaction.
García and his collaborators - including first author Christopher Johnson - chose lysostaphin, an enzyme that kills the bacteria by cleaving cell walls without generating inflammation. The enzyme keeps working within the hydrogel after it polymerizes.
"With this strategy, we can get rid of the bacteria in such a way that the body re-establishes a normal inflammatory environment that allows the bone to heal," García said. "Use of lysostaphin has been limited by poor stability inside the body, but in the gel, it can maintain stability for at least two weeks. That allows for controlled release over a longer period of time, which is sufficient for what we are trying to do."
For instance, if a screw was being inserted to repair an injury, the hydrogel might be applied to the screw threads. The soft gel would not affect the repair.
The next step in the research would be to repeat the study in large animals, after which clinical trials could be considered if the material proves promising.
"The mechanisms used to fight off infection depends on the species," Garcia noted. "That's why it's so important to repeat the studies in a large animal after testing in mice or rats. Showing efficacy in a large animal model would be a key step toward human trials."
The hydrogel material has been used in the human body before, and is designed to quickly leave the treatment site. "The hydrogel breaks down into small building blocks that are excreted in the urine," Garcia said. "After several weeks, there is no synthetic material left in the body and it is replaced by normal healing tissue."
Source: Eurekalert
Osteomyelitis
An infection of a bone is called osteomyelitis. Osteomyelitis can be acute or a chronic and can spread through the haematogenous or contiguous route.
Advertisement
Bone infections today are often treated with systemic antibiotics and surgery to clean the injury. If the infection occurs with implants, they often must be removed. Once the infection is gone, additional surgery may be required to implant proteins that stimulate bone regrowth and restore the implant. And the dead bacteria can prompt a harmful inflammatory reaction.
García and his collaborators - including first author Christopher Johnson - chose lysostaphin, an enzyme that kills the bacteria by cleaving cell walls without generating inflammation. The enzyme keeps working within the hydrogel after it polymerizes.
"With this strategy, we can get rid of the bacteria in such a way that the body re-establishes a normal inflammatory environment that allows the bone to heal," García said. "Use of lysostaphin has been limited by poor stability inside the body, but in the gel, it can maintain stability for at least two weeks. That allows for controlled release over a longer period of time, which is sufficient for what we are trying to do."
For instance, if a screw was being inserted to repair an injury, the hydrogel might be applied to the screw threads. The soft gel would not affect the repair.
The next step in the research would be to repeat the study in large animals, after which clinical trials could be considered if the material proves promising.
"The mechanisms used to fight off infection depends on the species," Garcia noted. "That's why it's so important to repeat the studies in a large animal after testing in mice or rats. Showing efficacy in a large animal model would be a key step toward human trials."
The hydrogel material has been used in the human body before, and is designed to quickly leave the treatment site. "The hydrogel breaks down into small building blocks that are excreted in the urine," Garcia said. "After several weeks, there is no synthetic material left in the body and it is replaced by normal healing tissue."
Source: Eurekalert
Silver Ion-Releasing Scaffolds to Treat MRSA Bone Infection
Hybrid therapeutic approaches such as a combination of a regenerative and anti-infective platform are transforming our attack on complex musculoskeletal diseases.
Advertisement
 New Model for Staph Bone Infections Outlined By Vanderbilt StudiesOsteomyelitis is a debilitating bone infection. It is most frequently caused by Staphylococcus aureus ( staph ) bacteria and is particularly challenging to treat. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.
Link between advanced paternal age and higher risks for reproductive and offspring medical problems has been discovered.